Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
BMC Psychiatry|November 17, 2023
Study protocol for Ketamine as an adjunctive therapy for major depression (2): a randomised controlled trial (KARMA-Dep [2])Ana Jelovac, Cathal McCaffrey, Masashi Terao, et al.
Human Molecular Genetics|September 12, 2009
X11beta rescues memory and long-term potentiation deficits in Alzheimer's disease APPswe Tg2576 miceJacqueline C Mitchell, Belall B Ariff, Darran M Yates, et al.
Applied Neuropsychology. Adult|February 25, 2020
A pilot study of cognitive remediation in remitted major depressive disorder patientsÅsa Hammar, Maria Semkovska, Ida M H Borgen, et al.
The Journal of Biological Chemistry|September 13, 2003
The neuronal adaptor protein X11alpha reduces Abeta levels in the brains of Alzheimer's APPswe Tg2576 transgenic miceJu-Hyun Lee, Kwok-Fai Lau, Michael S Perkinton, et al.
Neuroscience and Biobehavioral Reviews|February 12, 2025
Inflammatory markers associated with electroconvulsive therapy response in patients with depression: A meta-analysisAnnelies Dellink, Gertjan Vanderhaegen, Violette Coppens, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 2, 2003
Identification of a novel, membrane-associated neuronal kinase, cyclin-dependent kinase 5/p35-regulated kinaseSashi Kesavapany, Kwok-Fai Lau, Steven Ackerley, et al.
Journal of Cellular Biochemistry|January 22, 2010
Transcriptional regulation of human FE65, a ligand of Alzheimer's disease amyloid precursor protein, by Sp1Hoi-Tin Yu, William Wai-Lun Chan, Ka-Ho Chai, et al.
Pageof 15